In this context, recent studies in ovarian cancer demonstrated that halofuginone, a natural compound that suppresses COL1A1 production, disrupted collagen deposition, remodeled the tumor microenvironment, and improved chemosensitivity [23]. Here, COL1A1 is linked to ovarian cancer.